See ratings and reviews when you sign up for an account.

Neuraxial Pethidine After Lumbar Surgery Trial

This study is currently Recruiting

January 2009 By Austin Health

First Recieved on September 9, 2005

Last Updated on January 29, 2009

Sponsor: Austin Health
Information provided by: Austin Health
Identifier: NCT00163553


The hypothesis is that epidural pethidine is an effective form of pain relief following lumbar spinal surgery, resulting in significantly lower usage of concomitantly administered (intravenous) patient-controlled analgesia (PCA) pethidine.

Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Inclusion Criteria: - Adults undergoing lumbar spinal surgery Exclusion Criteria: - Lack of informed patient consent - Acute or chronic renal failure - Known allergy or intolerance to pethidine or tramadol - Chronic respiratory insufficiency - Epidural contraindicated (coagulopathy, systemic infection)


  • Investigator: Dean A Cowie, MBBS, FANZCA - Principal Investigator - Austin Health


  • Austin Health

    Melbourne, Victoria 3084 Australia

Conditions related to this trial:

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.